Head-to-head · WeighScore
InstaRX vs Velvet Rx
The verdict
InstaRX takes it — 63.8/100 to 58.1/100.
InstaRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. InstaRX is a multi-product compounded-medication telehealth platform offering GLP-1 injections (semaglutide and tirzepatide) alongside anti-aging peptides (NAD+, Sermorelin, B12/MIC) and sexual-health…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | InstaRX | Velvet Rx |
|---|---|---|
| WeighScore | 63.8/100 | 58.1/100 |
| Grade | C | C |
| Scorecard rank | #250 | #381 |
| Semaglutide | $199/mo (starting dose, compounded) | $299/mo (compounded) |
| Tirzepatide | $199/mo (starting dose, compounded) | $359/mo (compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #250 · C
Strengths
- Available in all 50 states plus DC
- Manage GLP-1, anti-aging peptides, and sexual-health medications on one account
- Offers both compounded semaglutide and compounded tirzepatide
- Independent provider group (Dr Telx) named in the Terms of Service
Where it loses points
- No per-dose or monthly pricing published — only a "$199 to get started" hook; you can't compare costs before intake
- No LegitScript, HIPAA, or NABP accreditation shown on public pages
- Compounding pharmacy not named — only "U.S. pharmacies"
- Terms of Service reads like generic boilerplate, including copy-paste language about women's health issues — suggests low template hygiene
- Delaware governing law for disputes despite a California corporate address
Graded #381 · C
Strengths
- Public pricing across 3 SKUs (semaglutide $299, tirzepatide $359, oral GLP-1 $349) — uncommon in compounded telehealth
- First-month promo pricing shown upfront ($139 sema / $199 tirz / $189 oral)
- Single monthly price includes consult, prescription, 4 weeks of medication, and free 1–2 day shipping
- FSA/HSA eligible
- Three options under one roof: injectable sema, injectable tirz, and an oral GLP-1
Where it loses points
- Oral GLP-1 SKU doesn't name the specific drug — a real gap given Rybelsus, Foundayo, and compounded oral semaglutide differ clinically
- No LegitScript or NABP .pharmacy seal displayed
- No legal entity name disclosed
- No physical address disclosed
- Compounding pharmacy partner not named
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.